- Home
- GHI vs HRTX Comparison
GHI vs HRTX Comparison
Compare GHI & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHI
- HRTX
- Stock Information
- Founded
- GHI 1998
- HRTX 1983
- Country
- GHI United States
- HRTX United States
- Employees
- GHI N/A
- HRTX N/A
- Industry
- GHI Finance: Consumer Services
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- GHI Finance
- HRTX Health Care
- Exchange
- GHI Nasdaq
- HRTX Nasdaq
- Market Cap
- GHI 264.1M
- HRTX 350.4M
- IPO Year
- GHI N/A
- HRTX 1987
- Fundamental
- Price
- GHI $11.43
- HRTX $2.17
- Analyst Decision
- GHI Strong Buy
- HRTX Strong Buy
- Analyst Count
- GHI 4
- HRTX 2
- Target Price
- GHI $16.00
- HRTX $5.50
- AVG Volume (30 Days)
- GHI 40.7K
- HRTX 1.8M
- Earning Date
- GHI 05-07-2025
- HRTX 05-06-2025
- Dividend Yield
- GHI 12.90%
- HRTX N/A
- EPS Growth
- GHI N/A
- HRTX N/A
- EPS
- GHI 0.45
- HRTX N/A
- Revenue
- GHI $34,065,322.00
- HRTX $148,518,000.00
- Revenue This Year
- GHI $232.85
- HRTX $11.18
- Revenue Next Year
- GHI N/A
- HRTX $13.15
- P/E Ratio
- GHI $25.63
- HRTX N/A
- Revenue Growth
- GHI N/A
- HRTX 12.43
- 52 Week Low
- GHI $10.12
- HRTX $1.04
- 52 Week High
- GHI $15.80
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- GHI 44.56
- HRTX 49.30
- Support Level
- GHI $11.27
- HRTX $2.00
- Resistance Level
- GHI $12.70
- HRTX $2.61
- Average True Range (ATR)
- GHI 0.45
- HRTX 0.18
- MACD
- GHI 0.01
- HRTX 0.01
- Stochastic Oscillator
- GHI 16.98
- HRTX 45.00
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.